Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients

BACKGROUND: Treatment of hyperphosphataemia is the primary goal of chronic kidney disease–mineral and bone disorder (CKD-MBD) management. This post hoc analysis of a randomized, Phase 3 study evaluated the effects of 1-year treatment with the phosphate binders sucroferric oxyhydroxide or sevelamer c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Nephrol Dial Transplant
Hoofdauteurs: Ketteler, Markus, Sprague, Stuart M, Covic, Adrian C, Rastogi, Anjay, Spinowitz, Bruce, Rakov, Viatcheslav, Walpen, Sebastian, Floege, Jürgen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
ORIGINAL ARTICLES
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6603395/
https://ncbi.nlm.nih.gov/pubmed/29846719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy127
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items